Market Tracker

04/29 4:01am ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.85
Delayed Data
As of Apr 28
 -0.22 / -2.43%
Today’s Change
4.15
Today|||52-Week Range
10.74
+3.51%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close9.07
Today’s open9.10
Day’s range8.85 - 9.37
Volume50,527
Average volume (3 months)58,582
Market cap$119.0M
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...+0.87+7.51%
ARQLArQule Inc0.000.00%
--Sun Biopharma Inc0.000.00%
GLYCGlycoMimetics Inc-0.12-1.89%
Data as of 04/28/2016

Financials

Last reporting dateApril 29, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts